{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:02:00Z","timestamp":1789977720675,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.canep.2011.12.007","type":"journal-article","created":{"date-parts":[[2012,1,29]],"date-time":"2012-01-29T23:59:32Z","timestamp":1327881572000},"page":"e183-e189","source":"Crossref","is-referenced-by-count":9,"title":["Behavioral and sociodemographic risk factors for serological and DNA evidence of HPV6, 11, 16, 18 infections"],"prefix":"10.1016","volume":"36","author":[{"given":"Dorothy J.","family":"Wiley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel V.","family":"Masongsong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sings","family":"Heather L.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benissa","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Ault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darron R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canep.2011.12.007_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2710.2009.01150.x","article-title":"Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics","volume":"36","author":"Pomfret","year":"2011","journal-title":"J Clin Pharm Ther"},{"issue":"9686","key":"10.1016\/j.canep.2011.12.007_bib0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.canep.2011.12.007_bib0015","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.canep.2011.12.007_bib0020","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"issue":"c3493","key":"10.1016\/j.canep.2011.12.007_bib0025","first-page":"1","article-title":"Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial","volume":"341","author":"Dillner","year":"2010","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.canep.2011.12.007_bib0030","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","article-title":"A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions","volume":"2","author":"Kjaer","year":"2009","journal-title":"Cancer Prev Res (Phila Pa)"},{"issue":"2 Suppl.","key":"10.1016\/j.canep.2011.12.007_bib0035","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ygyno.2010.01.027","article-title":"Prevention strategies against human papillomavirus in males","volume":"117","author":"Garland","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"20","key":"10.1016\/j.canep.2011.12.007_bib0040","first-page":"630","article-title":"FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.canep.2011.12.007_bib0045","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/sti.2009.037788","article-title":"Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women","volume":"85","author":"Fairley","year":"2009","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.canep.2011.12.007_bib0050","series-title":"Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth","first-page":"1","author":"Chandra","year":"2005"},{"key":"10.1016\/j.canep.2011.12.007_bib0055","series-title":"USDoHaH. Women's Health USA, 2010","first-page":"80","author":"Services","year":"2010"},{"key":"10.1016\/j.canep.2011.12.007_bib0060","series-title":"Sexually transmitted diseases: Figure B Data, All States: Chlamydia positivity in women 15\u201324 years of age by testing site, 2000\u20132009","first-page":"1","author":"U.S. Center for Disease Control and Prevention","year":"2009"},{"issue":"1","key":"10.1016\/j.canep.2011.12.007_bib0065","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1158\/1055-9965.EPI-10-0682","article-title":"The epidemiology of oral HPV infection among a multinational sample of healthy men","volume":"20","author":"Kreimer","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1016\/j.canep.2011.12.007_bib0070","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4161\/hv.5.10.9515","article-title":"Evaluation of quadrivalent HPV 6\/11\/16\/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection","volume":"5","author":"Olsson","year":"2009","journal-title":"Hum Vaccin"},{"issue":"8","key":"10.1016\/j.canep.2011.12.007_bib0075","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.vaccine.2007.11.088","article-title":"Using risk factors to predict human papillomavirus infection: implications for targeted vaccination strategies in young adult women","volume":"26","author":"Dempsey","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.canep.2011.12.007_bib0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurpub\/ckp141","article-title":"A cost-utility analysis of adding a bivalent or quadrivalent HPV vaccine to the Irish cervical screening programme","volume":"20","author":"Dee","year":"2010","journal-title":"Eur J Public Health"},{"issue":"3","key":"10.1016\/j.canep.2011.12.007_bib0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00019053-200927030-00006","article-title":"Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium","volume":"27","author":"Annemans","year":"2009","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"10.1016\/j.canep.2011.12.007_bib0090","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jnci\/djh104","article-title":"Projected clinical benefits and cost-effectiveness of a human papillomavirus 16\/18 vaccine","volume":"96","author":"Goldie","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canep.2011.12.007_bib0095","doi-asserted-by":"crossref","DOI":"10.1111\/j.1524-4733.2009.00512.x","article-title":"Age-Based Programs for Vaccination against HPV","author":"Elbasha","year":"2009","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.canep.2011.12.007_bib0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000192397.41191.fb","article-title":"Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial","volume":"107","author":"Mao","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.canep.2011.12.007_bib0105","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1128\/CDLI.12.8.959-969.2005","article-title":"Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18","volume":"12","author":"Dias","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"10","key":"10.1016\/j.canep.2011.12.007_bib0110","first-page":"1021","article-title":"An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV)","volume":"10","author":"Castle","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.canep.2011.12.007_bib0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/sti.74.1.45","article-title":"Racial origin, sexual lifestyle, and genital infection among women attending a genitourinary medicine clinic in London (1992)","volume":"74","author":"Evans","year":"1998","journal-title":"Sex Transm Infect"},{"issue":"3","key":"10.1016\/j.canep.2011.12.007_bib0120","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1067\/mob.2003.164","article-title":"Clinical findings among young women with genital human papillomavirus infection","volume":"188","author":"Mao","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.canep.2011.12.007_bib0125","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/339884","article-title":"Characterization of vaginal flora and bacterial vaginosis in women who have sex with women","volume":"185","author":"Marrazzo","year":"2002","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.canep.2011.12.007_bib0130","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1086\/315080","article-title":"High prevalence and incidence of sexually transmitted diseases in urban adolescent females despite moderate risk behaviors","volume":"180","author":"Bunnell","year":"1999","journal-title":"J Infect Dis"},{"issue":"No. RR-6","key":"10.1016\/j.canep.2011.12.007_bib0135","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR"},{"key":"10.1016\/j.canep.2011.12.007_bib0140","unstructured":"SAS Institute Inc. SAS: The Frequency Procedure. [Online; Index] Cary: SAS Institute Inc.; 2010. Available at: http:\/\/support.sas.com\/documentation\/cdl\/en\/statug\/63347\/HTML\/default\/viewer.htm#\/documentation\/cdl\/en\/statug\/63347\/HTML\/default\/freq_toc.htm."},{"key":"10.1016\/j.canep.2011.12.007_bib0145","unstructured":"SAS Institute Inc. SAS: The Logistic Procedure. [Online; Index] Cary: SAS Institute Inc.; 2010. Available at: http:\/\/support.sas.com\/documentation\/cdl\/en\/statug\/63347\/HTML\/default\/viewer.htm#\/documentation\/cdl\/en\/statug\/63347\/HTML\/default\/logistic_toc.htm."},{"issue":"2","key":"10.1016\/j.canep.2011.12.007_bib0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jmv.20447","article-title":"Epidemiologic correlates of cervical human papillomavirus prevalence in women with abnormal Pap smear tests: a Taiwan Cooperative Oncology Group (TCOG) study","volume":"77","author":"Sun","year":"2005","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.canep.2011.12.007_bib0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1086\/338010","article-title":"Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types","volume":"185","author":"Chan","year":"2002","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.canep.2011.12.007_bib0160","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00007435-200203000-00009","article-title":"Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity","volume":"29","author":"Castle","year":"2002","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.canep.2011.12.007_bib0165","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00007435-199611000-00012","article-title":"Risk factors for HPV DNA detection in middle-aged women","volume":"23","author":"Munoz","year":"1996","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.canep.2011.12.007_bib0170","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0895-4356(92)90170-R","article-title":"The relationship between contraceptives, sexual practices, and cervical human papillomavirus infection among a college population","volume":"45","author":"Burkett","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.canep.2011.12.007_bib0175","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.canep.2011.12.007_bib0180","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1158\/1055-9965.1574.13.10","article-title":"A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus","volume":"13","author":"Shields","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.canep.2011.12.007_bib0185","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1158\/1055-9965.EPI-08-0591","article-title":"Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants","volume":"18","author":"Wang","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"10.1016\/j.canep.2011.12.007_bib0190","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/428850","article-title":"Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica","volume":"191","author":"Herrero","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.canep.2011.12.007_bib0195","series-title":"Table 3: female population by age, sex, race and hispanic or latino origin for the United States: 2000","author":"U.S. Bureau of the Census","year":"2000"},{"key":"10.1016\/j.canep.2011.12.007_bib0200","series-title":"Women and smoking: a report of the surgeon general","author":"Office on Smoking and Health","year":"2001"},{"issue":"4","key":"10.1016\/j.canep.2011.12.007_bib0205","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ogc.2008.09.006","article-title":"Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer","volume":"35","author":"Wheeler","year":"2008","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"5","key":"10.1016\/j.canep.2011.12.007_bib0210","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00007435-199309000-00007","article-title":"Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon","volume":"20","author":"Bauer","year":"1993","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.canep.2011.12.007_bib0215","first-page":"1129","article-title":"Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control","volume":"10","author":"Giuliano","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.canep.2011.12.007_bib0220","first-page":"788","article-title":"Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis","volume":"18","author":"Bae","year":"2008","journal-title":"J Microbiol Biotechnol"},{"issue":"4","key":"10.1016\/j.canep.2011.12.007_bib0225","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/341782","article-title":"Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study","volume":"186","author":"Giuliano","year":"2002","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.canep.2011.12.007_bib0230","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/OLQ.0b013e31815ac5c7","article-title":"Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women","volume":"35","author":"Nielsen","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"8","key":"10.1016\/j.canep.2011.12.007_bib0235","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1086\/521679","article-title":"Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine","volume":"196","author":"Giuliano","year":"2007","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.canep.2011.12.007_bib0240","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/jnci\/83.14.997","article-title":"Determinants of genital human papillomavirus infection in young women","volume":"83","author":"Ley","year":"1991","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.canep.2011.12.007_bib0245","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjose","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.canep.2011.12.007_bib0250","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.canep.2011.12.007_bib0255","first-page":"615","article-title":"Risk factors for high-risk type human papillomavirus infection among Mexican-American women","volume":"8","author":"Giuliano","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"18","key":"10.1016\/j.canep.2011.12.007_bib0260","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/87.18.1365","article-title":"Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia","volume":"87","author":"Ho","year":"1995","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.canep.2011.12.007_bib0265","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/infdis\/173.6.1394","article-title":"Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior","volume":"173","author":"Dillner","year":"1996","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.canep.2011.12.007_bib0270","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/infdis\/174.4.679","article-title":"Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women","volume":"174","author":"Burk","year":"1996","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.canep.2011.12.007_bib0275","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/380466","article-title":"Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population","volume":"189","author":"Tarkowski","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.canep.2011.12.007_bib0380","series-title":"Sexually Transmitted Disease Surveillance, 2000","author":"Centers for Disease Control and Prevention","year":"2001"},{"issue":"5","key":"10.1016\/j.canep.2011.12.007_bib0285","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/sti.2010.044354","article-title":"Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia","volume":"87","author":"Lehtinen","year":"2011","journal-title":"Sex Transm Infect"},{"issue":"4","key":"10.1016\/j.canep.2011.12.007_bib0290","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000156481","article-title":"Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways","volume":"51","author":"Paba","year":"2008","journal-title":"Intervirology"},{"key":"10.1016\/j.canep.2011.12.007_bib0295","doi-asserted-by":"crossref","first-page":"319460","DOI":"10.1155\/2011\/319460","article-title":"Bacterial vaginosis and the natural history of human papillomavirus","volume":"2011","author":"King","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.canep.2011.12.007_bib0300","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1086\/344354","article-title":"Seroprevalence of human papillomavirus type 16 infection in the United States","volume":"186","author":"Stone","year":"2002","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.canep.2011.12.007_bib0305","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/jnci\/92.6.464","article-title":"Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica","volume":"92","author":"Herrero","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canep.2011.12.007_bib0310","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476","article-title":"Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia","volume":"31","author":"Schiffman","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"10.1016\/j.canep.2011.12.007_bib0315","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijgo.2004.07.013","article-title":"Persistent HPV infection in postmenopausal age women","volume":"87","author":"Smith","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"issue":"12","key":"10.1016\/j.canep.2011.12.007_bib0320","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1086\/324579","article-title":"Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection","volume":"184","author":"Rousseau","year":"2001","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.canep.2011.12.007_bib0325","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/ijc.23679","article-title":"Host and viral factors in relation to clearance of human papillomavirus infection: a cohort study in Taiwan","volume":"123","author":"Lai","year":"2008","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.canep.2011.12.007_bib0330","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/OLQ.0b013e31815abaef","article-title":"Seroepidemiology of human papillomavirus type 11 in the United States: results from the third National Health and Nutrition Examination Survey, 1991\u20131994","volume":"35","author":"Hariri","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.canep.2011.12.007_bib0335","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/342972","article-title":"Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles","volume":"186","author":"Ho","year":"2002","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.canep.2011.12.007_bib0340","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ijc.10868","article-title":"Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma","volume":"103","author":"de Villiers","year":"2003","journal-title":"Int J Cancer"},{"issue":"9312","key":"10.1016\/j.canep.2011.12.007_bib0345","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","article-title":"Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study","volume":"359","author":"Moreno","year":"2002","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.canep.2011.12.007_bib0350","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.canep.2011.12.007_bib0355","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.canep.2011.12.007_bib0360","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000107679","article-title":"Changes in the immune system after moderate beer consumption","volume":"51","author":"Romeo","year":"2007","journal-title":"Ann Nutr Metab"},{"issue":"2","key":"10.1016\/j.canep.2011.12.007_bib0365","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2249.1996.d01-621.x","article-title":"Loss of the CD5+ and CD45RAhi B cell subsets in alcoholics","volume":"103","author":"Cook","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.canep.2011.12.007_bib0370","first-page":"1927","article-title":"Alcohol abuse, alcoholism, and damage to the immune system \u2013 a review","volume":"22","author":"Cook","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.canep.2011.12.007_bib0375","series-title":"Cochran-Armitage trend test using SAS. SAS conference proceedings: PharmaSUG 2007","year":"2007"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782111002013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782111002013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T03:26:00Z","timestamp":1686713160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782111002013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1877782111002013"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2011.12.007","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}